Subjects: “…Alkaloids.…”
Access E-Book

Subjects: “…Alkaloids -- Scandinavia.…”
Access E-Book

Table of Contents: “…Ma Huang and the Ephedra Alkaloids /…”
Access E-Book

Table of Contents: “…Secondary metabolism : the building blocks and construction mechanisms -- The acetate pathway : fatty acids and polyketides -- The shikimate pathway : aromatic amino acids and phenylpropanoids -- The mevalonate and deoxyxylulose phosphate pathways : terpanoids and steroids -- Alkaloids -- Peptides, proteins and other amino acid derivatives -- Carbohydrates.…”
Access E-Book

Table of Contents: “…Phenols, polyphenols, and tannins : an overview -- Sulphur-containing compounds -- Terpenes -- Alkaloids -- Acetylenes and psoralens -- Functions of the human intestinal flora : the use of probiotics and prebiotics -- Secondary metabolites in fruits, vegetables, beverages and other plant-based dietary components -- Absorption and metabolism of plant secondary metabolites.…”
Access E-Book

Table of Contents: “…Bulger ; Ring rearrangement metathesis (RRM) in alkaloid synthesis / Nicole Holub and Siegfried Blechert ; Asymmetric synthesis of biaryls by the 'Lactone method' / Gerhard Bringmann, Tanja Gulder and Tobias A.M. …”

Table of Contents: “…Newton -- Neurologic complications of antimetabolites / Ryan Merrell, Jorg Dietrich, and Tracy Batchelor -- Neurologic complications associated with plant alkaloids / Abhishek Singla, Aditya Bardia, and Vinay Chaudhry -- Neurologic complications of topoisomerase inhibitors / April F. …”
Access E-Book

Table of Contents: “…Acknowledgments -- Introduction -- Just say know (a college student's perspective / Leigh Heather Wilson and Jeremy Foster) -- Test your drug knowledge -- Part 1: Alcohol: liquor, whiskey, booze, hooch, wine, beer, ale, porter -- Caffeine: coffee, tea, soft drinks, energy drinks, over-the-counter pain relievers and stimulants, some prescription medications -- Ecstasy: MDMA (X, XTC, Adam), MDE (Eve), MDA (love) -- Hallucinogens: lysergic acid diethylamide (LSD-acid, blotter, California sunshine, microdot, trip, yellow sunshine, etc); mescaline (peyote, buttons, mesc, mescal, topi); psilocybin mushrooms (boomers, magic mushrooms, shrooms); dimethyltryptamine (DMT-businessman's special); ayahuasca (caapi, yage, vegetal); belladonna alkaloids (atropine, scopolamine, belladonna, deadly nightshade, jimsonweed, stink weed, mandrake); phencyclidine (PCP, angel dust, T, peace pill); ketamine (special K, K); dextromethorphan (dex, robo, red devils); salvia divinorum (ska, Maria, la Maria, ska Pastora) -- Herbal drugs: herbal x-tacy, smart drugs, ginseng, melatonin, etc -- Inhalants: nitrates (butyl or amyl-bolt, bullets, climax, locker room, rush, poppers, snappers, aimes); anesthetics (nitrous oxide-whippets; gaseous anesthesia agents used for surgery-halothane ether); solvents, paints, sprays, and fuels (toluene, gasoline, glues, canned spray paint, etc) -- Marijuana: marijuana (reefer, pot, herb, ganja, grass, old man, blanche, weed, sinsemilla, bhang, dagga, smoke); hashish (hash, tar); hash oil (oil, charas).…”

Table of Contents: “…Cocaine -- Cocaine is isolated ; A new alkaloid in coca / American Journal of Pharmacy -- Praise for coca extract ; Erythroxylon coca / G. …”

Table of Contents: “…PART I: BASIC PRINCIPLES -- Chapter 1: Introduction -- Chapter 2: Pharmacodynamics -- Chapter 3: Pharmacokinetics -- Chapter 4: Drug Metabolism -- Chapter 5: Pharmacogenomics -- PART II: AUTONOMIC DRUGS -- Chapter 6: Introduction to Autonomic Pharmacology -- Chapter 7: Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs -- Chapter 8: Cholinoceptor Blockers & Cholinesterase Regenerators -- Chapter 9: Sympathomimetics -- Chapter 10: Adrenoceptor Blockers -- PART III: CARDIOVASCULAR DRUGS -- Chapter 11: Drugs Used in Hypertension -- Chapter 12: Drugs Used in the Treatment of Angina Pectoris -- Chapter 13: Drugs Used in Heart Failure -- Chapter 14: Antiarrhythmic Drugs -- Chapter 15: Diuretics & Other Drugs That Act on the Kidney -- PART IV: DRUGS WITH IMPORTANT ACTIONS ON SMOOTH MUSCLE -- Chapter 16: Histamine, Serotonin, Drugs Used in Obesity, & the Ergot Alkaloids -- Chapter 17: Vasoactive Peptides -- Chapter 18: Prostaglandins & Other Eicosanoids -- Chapter 19: Nitric Oxide, Donors, & Inhibitors -- Chapter 20: Drugs Used in Asthma & Chronic Obstructive Pulmonary Disease -- PART V: DRUGS THAT ACT IN THE CENTRAL NERVOUS SYSTEM -- Chapter 21: Introduction to CNS Pharmacology -- Chapter 22: Sedative-Hypnotic Drugs -- Chapter 23: Alcohols -- Chapter 24: Antiseizure Drugs -- Chapter 25: General Anesthetics -- Chapter 26: Local Anesthetics -- Chapter 27: Skeletal Muscle Relaxants -- Chapter 28: Drugs Used in Parkinsonism & Other Movement Disorders -- Chapter 29: Antipsychotic Agents & Lithium -- Chapter 30: Antidepressants -- Chapter 31: Opioid Analgesics & Antagonists -- Chapter 32: Drugs of Abuse -- PART VI: DRUGS WITH IMPORTANT ACTIONS ON BLOOD, INFLAMMATION, & GOUT -- Chapter 33: Agents Used in Cytopenias; Hematopoietic Growth Factors -- Chapter 34: Drugs Used in Coagulation Disorders -- Chapter 35: Agents Used in Dyslipidemia -- Chapter 36: NSAIDs, Acetaminophen, & Drugs Used in Rheumatoid Arthritis & Gout -- PART VII: ENDOCRINE DRUGS -- Chapter 37: Hypothalamic & Pituitary Hormones -- Chapter 38: Thyroid & Antithyroid Drugs -- Chapter 39: Adrenocorticosteroids & Adrenocortical Antagonists -- Chapter 40: Gonadal Hormones & Inhibitors -- Chapter 41: Pancreatic Hormones, Antidiabetic Drugs, & Glucagon -- Chapter 42: Agents That Affect Bone Mineral Homeostasis -- PART VIII: CHEMOTHERAPEUTIC DRUGS -- Chemotherapeutic Drugs: Introduction -- Chapter 43: Beta-Lactam Antibiotics & Other Cell Wall- & Membrane-Active Antibiotics -- Chapter 44: Tetracyclines, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, & Oxazolidinones -- Chapter 45: Aminoglycosides & Spectinomycin -- Chapter 46: Sulfonamides, Trimethoprim, & Fluoroquinolones -- Chapter 47: Antimycobacterial Drugs -- Chapter 48: Antifungal Agents -- Chapter 49: Antiviral Agents -- Chapter 50: Miscellaneous Antimicrobial Agents & Disinfectants, Antiseptics, & Sterilants -- Chapter 51: Clinical Use of Antimicrobial Agents -- Chapter 52: Antiprotozoal Drugs -- Chapter 53: Clinical Pharmacology of the Antihelminthic Drugs -- Chapter 54: Cancer Chemotherapy -- Chapter 55: Immunopharmacology -- PART IX: TOXICOLOGY -- Chapter 56: Environmental & Occupational Toxicology -- Chapter 57: Heavy Metals -- Chapter 58: Management of the Poisoned Patient -- PART X: SPECIAL TOPICS -- Chapter 59: Drugs Used in Gastrointestinal Disorders -- Chapter 60: Dietary Supplements & Herbal Medications -- Chapter 61: Important Drug Interactions & Their Mechanisms -- Appendix I: Strategies for Improving Test Performance -- Appendix II: Key Words for Key Drugs.…”
Access E-Book

Table of Contents: “…PART I: BASIC PRINCIPLES -- Chapter 1: Introduction -- Chapter 2: Pharmacodynamics -- Chapter 3: Pharmacokinetics -- Chapter 4: Drug Metabolism -- Chapter 5: Pharmacogenomics -- PART II: AUTONOMIC DRUGS -- Chapter 6: Introduction to Autonomic Pharmacology -- Chapter 7: Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs -- Chapter 8: Cholinoceptor Blockers & Cholinesterase Regenerators -- Chapter 9: Sympathomimetics -- Chapter 10: Adrenoceptor Blockers -- PART III: CARDIOVASCULAR DRUGS -- Chapter 11: Drugs Used in Hypertension -- Chapter 12: Drugs Used in the Treatment of Angina Pectoris -- Chapter 13: Drugs Used in Heart Failure -- Chapter 14: Antiarrhythmic Drugs -- Chapter 15: Diuretics & Other Drugs That Act on the Kidney -- PART IV: DRUGS WITH IMPORTANT ACTIONS ON SMOOTH MUSCLE -- Chapter 16: Histamine, Serotonin, & the Ergot Alkaloids -- Chapter 17: Vasoactive Peptides -- Chapter 18: Prostaglandins & Other Eicosanoids -- Chapter 19: Nitric Oxide, Donors, & Inhibitors -- Chapter 20: Drugs Used in Asthma & Chronic Obstructive Pulmonary Disease -- PART V: DRUGS THAT ACT IN THE CENTRAL NERVOUS SYSTEM -- Chapter 21: Introduction to CNS Pharmacology -- Chapter 22: Sedative-Hypnotic Drugs -- Chapter 23: Alcohols -- Chapter 24: Antiseizure Drugs -- Chapter 25: General Anesthetics -- Chapter 26: Local Anesthetics -- Chapter 27: Skeletal Muscle Relaxants -- Chapter 28: Drugs Used in Parkinsonism & Other Movement Disorders -- Chapter 29: Antipsychotic Agents & Lithium -- Chapter 30: Antidepressants -- Chapter 31: Opioid Analgesics & Antagonists -- Chapter 32: Drugs of Abuse -- PART VI: DRUGS WITH IMPORTANT ACTIONS ON BLOOD, INFLAMMATION, & GOUT -- Chapter 33: Agents Used in Cytopenias; Hematopoietic Growth Factors -- Chapter 34: Drugs Used in Coagulation Disorders -- Chapter 35: Agents Used in Dyslipidemia -- Chapter 36: NSAIDs, Acetaminophen, & Drugs Used in Rheumatoid Arthritis & Gout -- PART VII: ENDOCRINE DRUGS -- Chapter 37: Hypothalamic & Pituitary Hormones -- Chapter 38: Thyroid & Antithyroid Drugs -- Chapter 39: Corticosteroids & Antagonists -- Chapter 40: Gonadal Hormones & Inhibitors -- Chapter 41: Pancreatic Hormones, Antidiabetic Agents, & Glucagon -- Chapter 42: Drugs That Affect Bone Mineral Homeostasis -- PART VIII: CHEMOTHERAPEUTIC DRUGS -- Chemotherapeutic Drugs: Introduction -- Chapter 43: Beta-Lactam Antibiotics & Other Cell Wall Synthesis Inhibitors -- Chapter 44: Chloramphenicol, Tetracyclines, Macrolides, Clindamycin, Streptogramins, & Linezolid -- Chapter 45: Aminoglycosides -- Chapter 46: Sulfonamides, Trimethoprim, & Fluoroquinolones -- Chapter 47: Antimycobacterial Drugs -- Chapter 48: Antifungal Agents -- Chapter 49: Antiviral Chemotherapy & Prophylaxis -- Chapter 50: Miscellaneous Antimicrobial Agents & Urinary Antiseptics -- Chapter 51: Clinical Use of Antimicrobials -- Chapter 52: Antiprotozoal Drugs -- Chapter 53: Antihelminthic Drugs -- Chapter 54: Cancer Chemotherapy -- Chapter 55: Immunopharmacology -- PART IX: TOXICOLOGY -- Chapter 56: Environmental & Occupational Toxicology -- Chapter 57: Heavy Metals -- Chapter 58: Management of the Poisoned Patient -- PART X: SPECIAL TOPICS -- Chapter 59: Drugs Used in Gastrointestinal Disorders -- Chapter 60: Dietary Supplements & Herbal Medications -- Chapter 61: Drug Interactions -- Appendix I: Strategies for Improving Test Performance -- Appendix II: Key Words for Key Drugs -- Appendix III: Examination 1 -- Appendix IV: Examination 2.…”
Access E-Book

Table of Contents: “…SECTION I:BASIC PRINCIPLES -- CHAPTER 1:℗¡ Introduction: The Nature of Drugs & Drug Development & Regulation -- CHAPTER 2:℗¡ Drug Receptors & Pharmacodynamics -- CHAPTER 3:℗¡ Pharmacokinetics & Pharmacodynamics: Rational Dosing & the Time Course of Drug Action -- CHAPTER 4:℗¡ Drug Biotransformation -- CHAPTER 5:℗¡ Pharmacogenomics -- SECTION II:AUTONOMIC DRUGS -- CHAPTER 6:℗¡ Introduction to Autonomic Pharmacology -- CHAPTER 7:℗¡ Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs -- CHAPTER 8:℗¡ Cholinoceptor-Blocking Drugs -- CHAPTER 9:℗¡ Adrenoceptor Agonists & Sympathomimetic Drugs -- CHAPTER 10:℗¡ Adrenoceptor Antagonist Drugs -- SECTION III:CARDIOVASCULAR-RENAL DRUGS -- CHAPTER 11:℗¡ Antihypertensive Agents -- CHAPTER 12:℗¡ Vasodilators & the Treatment of Angina Pectoris -- CHAPTER 13:℗¡ Drugs Used in Heart Failure -- CHAPTER 14:℗¡ Agents Used in Cardiac Arrhythmias -- CHAPTER 15:℗¡ Diuretic Agents -- SECTION IV:DRUGS WITH IMPORTANT ACTIONS ON SMOOTH MUSCLE -- CHAPTER 16:℗¡ Histamine, Serotonin, & the Ergot Alkaloids -- CHAPTER 17:℗¡ Vasoactive Peptides -- CHAPTER 18:℗¡ The Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, & Related Compounds -- CHAPTER 19:℗¡ Nitric Oxide -- CHAPTER 20:℗¡ Drugs Used in Asthma -- SECTION V:DRUGS THAT ACT IN THE CENTRAL NERVOUS SYSTEM -- CHAPTER 21:℗¡ Introduction to the Pharmacology of CNS Drugs -- CHAPTER 22:℗¡ Sedative-Hypnotic Drugs -- CHAPTER 23:℗¡ The Alcohols -- CHAPTER 24:℗¡ Antiseizure Drugs -- CHAPTER 25:℗¡ General Anesthetics -- CHAPTER 26:℗¡ Local Anesthetics -- CHAPTER 27:℗¡ Skeletal Muscle Relaxants -- CHAPTER 28:℗¡ Pharmacologic Management of Parkinsonism & Other Movement Disorders -- CHAPTER 29:℗¡ Antipsychotic Agents & Lithium -- CHAPTER 30:℗¡ Antidepressant Agents -- CHAPTER 31:℗¡ Opioid Agonists & Antagonists -- CHAPTER 32:℗¡ Drugs of Abuse -- SECTION VI:DRUGS USED TO TREAT DISEASES OF THE BLOOD, INFLAMMATION, & GOUT -- CHAPTER 33:℗¡ Agents Used in Cytopenias; Hematopoietic Growth Factors -- CHAPTER 34:℗¡ Drugs Used in Disorders of Coagulation -- CHAPTER 35:℗¡ Agents Used in Dyslipidemia -- CHAPTER 36:℗¡ Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics, & Drugs Used in Gout -- SECTION VII:ENDOCRINE DRUGS -- CHAPTER 37:℗¡ Hypothalamic & Pituitary Hormones -- CHAPTER 38:℗¡ Thyroid & Antithyroid Drugs -- CHAPTER 39:℗¡ Adrenocorticosteroids & Adrenocortical Antagonists -- CHAPTER 40:℗¡ The Gonadal Hormones & Inhibitors -- CHAPTER 41:℗¡ Pancreatic Hormones & Antidiabetic Drugs -- CHAPTER 42:℗¡ Agents That Affect Bone Mineral Homeostasis -- SECTION VIII:CHEMOTHERAPEUTIC DRUGS -- SECTION VIII:℗¡ CHEMOTHERAPEUTIC DRUGS: INTRODUCTION -- CHAPTER 43:℗¡ Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics -- CHAPTER 44:℗¡ Tetracyclines, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, & Oxazolidinones -- CHAPTER 45:℗¡ Aminoglycosides & Spectinomycin -- CHAPTER 46:℗¡ Sulfonamides, Trimethoprim, & Quinolones.…”
Access E-Book

Table of Contents: “…SECTION I: BASIC PRINCIPLES -- Chapter 1: Introduction: The Nature of Drugs & Drug Development & Regulation -- Chapter 2: Drug Receptors & Pharmacodynamics -- Chapter 3: Pharmacokinetics & Pharmacodynamics: Rational Dosing & the Time Course of Drug Action -- Chapter 4: Drug Biotransformation -- Chapter 5: Pharmacogenomics -- SECTION II: AUTONOMIC DRUGS -- Chapter 6: Introduction to Autonomic Pharmacology -- Chapter 7: Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs -- Chapter 8: Cholinoceptor-Blocking Drugs -- Chapter 9: Adrenoceptor Agonists & Sympathomimetic Drugs -- Chapter 10: Adrenoceptor Antagonist Drugs -- SECTION III: CARDIOVASCULAR-RENAL DRUGS -- Chapter 11: Antihypertensive Agents -- Chapter 12: Vasodilators & the Treatment of Angina Pectoris -- Chapter 13: Drugs Used in Heart Failure -- Chapter 14: Agents Used in Cardiac Arrhythmias -- Chapter 15: Diuretic Agents -- SECTION IV: DRUGS WITH IMPORTANT ACTIONS ON SMOOTH MUSCLE -- Chapter 16: Histamine, Serotonin, & the Ergot Alkaloids -- Chapter 17: Vasoactive Peptides -- Chapter 18: The Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, & Related Compounds -- Chapter 19: Nitric Oxide -- Chapter 20: Drugs Used in Asthma -- SECTION V: DRUGS THAT ACT IN THE CENTRAL NERVOUS SYSTEM -- Chapter 21: Introduction to the Pharmacology of CNS Drugs -- Chapter 22: Sedative-Hypnotic Drugs -- Chapter 23: The Alcohols -- Chapter 24: Antiseizure Drugs -- Chapter 25: General Anesthetics -- Chapter 26: Local Anesthetics -- Chapter 27: Skeletal Muscle Relaxants -- Chapter 28: Pharmacologic Management of Parkinsonism & Other Movement Disorders -- Chapter 29: Antipsychotic Agents & Lithium -- Chapter 30: Antidepressant Agents -- Chapter 31: Opioid Agonists & Antagonists -- Chapter 32: Drugs of Abuse -- SECTION VI: DRUGS USED TO TREAT DISEASES OF THE BLOOD, INFLAMMATION, & GOUT -- Chapter 33: Agents Used in Cytopenias; Hematopoietic Growth Factors -- Chapter 34: Drugs Used in Disorders of Coagulation -- Chapter 35: Agents Used in Dyslipidemia -- Chapter 36: Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics, & Drugs Used in Gout -- SECTION VII: ENDOCRINE DRUGS -- Chapter 37: Hypothalamic & Pituitary Hormones -- Chapter 38: Thyroid & Antithyroid Drugs -- Chapter 39: Adrenocorticosteroids & Adrenocortical Antagonists -- Chapter 40: The Gonadal Hormones & Inhibitors -- Chapter 41: Pancreatic Hormones & Antidiabetic Drugs -- Chapter 42: Agents That Affect Bone Mineral Homeostasis -- SECTION VIII: CHEMOTHERAPEUTIC DRUGS -- Section VIII: Chemotherapeutic Drugs: Introduction -- Chapter 43: Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics -- Chapter 44: Tetracyclines, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, & Oxazolidinones -- Chapter 45: Aminoglycosides & Spectinomycin -- Chapter 46: Sulfonamides, Trimethoprim, & Quinolones -- Chapter 47: Antimycobacterial Drugs -- Chapter 48: Antifungal Agents -- Chapter 49: Antiviral Agents -- Chapter 50: Miscellaneous Antimicrobial Agents; Disinfectants, Antiseptics, & Sterilants…”
Access E-Book

Table of Contents: “…Chapter 11: Pulmonary Diseases / Erin Redding and Shannon Despino -- Cystic fibrosis -- Genetics/incidence --Manifestations/diagnosis -- Management -- Effects of CF on nutritional status -- Nutritional screening and assessment -- Nutritional management -- Alternative/complementary medicine -- Identification of areas needing further research -- Bronchopulmonary dysplasia -- Increased nutrient requirements -- Effects of bronchopulmonary dysplasia -- Growth of infants with BPD -- Nutritional screening and assessment -- Nutrition management -- Barriers to meeting increased needs -- Meeting nutritional needs -- Addressing feeding difficulties -- Identification of areas needing further research -- Asthma -- Food allergies and asthma -- Effects of nutrients on asthma -- Effects of asthma treatment on nutritional status -- Nutritional management -- Combating steroid side effects -- Alternative/complementary medicine -- Identification of areas for further research -- Chapter 12: Gastrointestinal Disorders / Amanda Croll, Sarah Weston, Jennifer Autodore, and Jenni Beary -- Introduction -- Acute diarrhea -- Nutrition management -- Lactose-containing products -- Fiber-- Prebiotics and probiotics -- Chronic diarrhea -- Nutrition management -- Constipation -- Gastroesophageal reflux -- Lactose intolerance -- Primary lactase deficiency -- Secondary lactase deficiency -- Developmental (neonatal) lactase deficiency -- Congenital lactase deficiency -- Celia disease -- Inflammatory bowel disease -- Nutrition assessment -- Nutrition therapy -- Pancreatitis -- Nutrition therapy for mold pancreatitis -- Nutrition therapy for severe pancreatitis -- Cholestatic liver disease -- Nutrition assessment -- Nutrition therapy -- Liver transplant -- Nutrition assessment -- Pretransplant nutrition therapy -- Post-transplant nutrition therapy -- Short bowel syndrome -- Nutrient and fluid absorption -- Nutritional adequacy -- Phases of nutrition therapy -- Other treatments -- Intestinal transplantation -- Websites -- General gastrointestinal -- Celiac -- Magazines for people with food allergies and sensitivities -- Crohn's and colitis foundation of America -- Chapter 13: Chronic Kidney Disease / Linda A Phelan -- Stages, etiology, and consequences of chronic kidney disease -- Conservative management -- Calcium and phosphorus -- Sodium, potassium, and fluid -- Protein/energy -- Vitamins and minerals -- Dialysis -- Calcium and phosphorus -- Sodium, potassium, and fluid -- Protein/energy -- Lipids -- Vitamins -- Carnitine -- Transplantation -- Conclusion -- Chapter 14: Cardiology / Melanie Savoca, Monica Nagle, and Susan Konek -- Congenital heart disease -- Factors associated with malnutrition -- Acute care -- Extracorporeal life support -- Parenteral nutrition support -- Gastrointestinal function -- Enteral nutrition support -- Pediatric cardiomyopathy -- Chylothorax -- Genetic syndromes and chromosome anomalies -- Chronic care -- Pediatric Hyperlipidemia -- Chapter 15: Diabetes / Laurie Anne Higgins -- Introduction -- Diabetes team -- Nutrition principles for the management of diabetes and related complications -- Calories -- Carbohydrate and sweeteners -- Glycemic index and glycemic load -- Sucrose -- Nutritive sweeteners -- nonnutritive sweeteners -- Fiber -- Protein -- Total fat -- Vitamins and minerals -- Alcohol -- Designing the meal plan -- Nutrition counseling -- Meal-planning approaches -- Insulin therapy -- Snacks -- CSII/pump therapy -- Long-acting insulin's -- Age-specific developmental considerations -- Birth to 12 months of age -- One to 4 years of age -- School-age children -- Adolescents -- Growth maintenance -- Weight control and disrodered eating -- Type 2 diabetes -- Pregnancy -- Breastfeeding -- Monitoring blood glucose -- Continuous glucose monitoring -- Exercise/activity -- Hypoglycemia -- Illness -- Conclusion -- Chapter 16: HIV And AIDS / Jill Rockwell -- Overview -- Immune function and HIV/AIDS -- Definitions of AIDs surveillance of children -- Diagnosis -- Clinical manifestations of HIV infection and AIDs -- Medications -- Nutritional implications -- Growth and body composition -- Bone density -- Caloric requirements -- Nutritional intervention -- Conclusion -- Chapter 17: Hematology And Oncology / Paula Charuhas Macris and Kathryn Hunt -- Introduction -- Childhood cancer and malnutrition -- Nutritional effects of cancer therapy -- Chemotherapy -- Surgery -- Radiation therapy -- Hematopoietic cell transplantation -- Nutrition assessment -- Anthropometry -- Biochemistry -- Nutrition history -- Physical assessment -- Other assessment tools -- Nutrient requirements -- Energy and protein requirements -- Vitamins, minerals, and other requirements -- Nutrition support -- Oral diet -- Enteral nutrition -- Parenteral nutrition -- Special considerations -- Long-term nutritional sequelae -- Integrative medicine -- Diet for the immunosuppressed child -- Food safety -- Special food service needs -- Feeding relationship and family-centered care -- Promoting oral intake during hospitalization -- Sickle cell disease -- Nutrition education for children with SCD -- Conclusion -- Chapter 18: Nutrition For Burned Pediatric Patients / Michele Morath Gottschlich and Theresa Mayes -- Anatomic and physiologic considerations -- Metabolic manifestations of thermal injury -- Fluid requirements -- Caloric needs -- Carbohydrate needs -- Protein requirements -- Fat needs -- Micronutrient needs -- Nutritional intervention strategies -- Small burn (less than 20%) -- Larger surface burns (more that 20%) -- Parenteral hyperalimentation -- Nutritional assessment -- Conclusion -- Chapter 19: Enteral Nutrition / Lisa Simone Sharda -- Introduction -- Patient selection -- Product selection -- Infants less than 1 year of age -- Children older than 1 year -- Adolescents -- Blenderized feedings -- Commercial adult formulas -- Product availability and cost -- Selection of specific feeding routes -- Gastric feeding -- Transpyloric feedings -- Jejunostomy feeding -- Administration of feeding -- Methods of delivery -- Pumps -- Initiation and advancement of feedings -- Prevention and treatment of complications -- Hang time -- Transition to oral intake -- Weaning -- Formula change and acceptance -- Feeding disorders -- Planning for home enteral support -- Chapter 20: Parenteral Nutrition / Janice Hovasi Cox and Ingrida Mara Melbardis -- Introduction -- Clinical indications -- Vascular access -- Peripheral venous access -- Central venous access -- Solution administration -- Cycling -- Weaning -- Fluid and electrolytes -- Energy -- Carbohydrate -- Protein -- Fat -- Vitamins -- Minerals -- Patient monitoring -- Psychosocial issues -- Reimbursement -- Resources -- Chapter 21: Botanicals In Pediatrics / John Westerdahl -- Introduction -- Growth of the herbal market -- Definitions -- Use of herbs and phytomedicines in pediatrics -- Laxatives and stimulants -- Sedatives and antidepressants -- Herbs containing alkaloids -- Traditional herbal remedies used with infants and children -- Determining proper pediatric dosage for medicinal herbs -- Conclusion -- Resources -- Appendix A: Premature infant growth charts -- Appendix B: CDC and WHO growth charts -- Appendix C: Down syndrome growth charts -- Appendix D: Arm measurements -- Appendix E: Progression of sexual development Appendix F: Nomograms -- Appendix G: Biochemical evaluation of nutritional status -- Appendix H: Recommended dietary allowances/dietary reference intakes -- Appendix I: 2010 dietary guidelines -- Appendix J: Conversion tables -- Index.…”